ConductScience.org, home

Paper379462

The pathogenesis of atherosclerosis.

Ross R. Mech Ageing Dev, 1979. Cited by 29 papers, by iCite.

Cite this record

ConductScience Library. The pathogenesis of atherosclerosis. Papers, record 379462. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/379462

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The pathogenesis of atherosclerosis.
PubMed
Journal
Mech Ageing Dev
PubMed
Year
1979
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S., Review
PubMed
Citations, by iCite
29
iCite
Relative citation ratio, by iCite
0.74
iCite
Revised in PubMed
2019-08-27
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ross RR

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ArteriesMajor topic
ArteriosclerosisMajor topic
Blood PlateletsMajor topic
EndotheliumMajor topic
Muscle, SmoothMajor topic
Animals
Mitogens

Source PubMed

Download CSV of topics

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.

PMIDTitleJournalYearIn PapersSource
36737432The mechanism and therapy of aortic aneurysms.Signal Transduct Target Ther2023https://conductscience.org/library/papers/36737432PubMed
35682562The Interplay of Endothelial P2Y Receptors in Cardiovascular Health: From Vascular Physiology to Pathology.Int J Mol Sci2022https://conductscience.org/library/papers/35682562PubMed
32612287MiR-126-5p promotes contractile switching of aortic smooth muscle cells by targeting VEPH1 and alleviates Ang II-induced abdominal aortic aneurysm in mice.Lab Invest2020https://conductscience.org/library/papers/32612287PubMed
32565865Therapeutic Potential of Quercetin as an Antiatherosclerotic Agent in Atherosclerotic Cardiovascular Disease: A Review.Evid Based Complement Alternat Med2020https://conductscience.org/library/papers/32565865PubMed
31709573Histological variation of early stage atherosclerotic lesions in baboons after prolonged challenge with high-cholesterol, high-fat diet.J Med Primatol2020https://conductscience.org/library/papers/31709573PubMed
30965617A Low-Molecular-Weight Polyethylenimine/pDNA-VEGF Polyplex System Constructed in a One-Pot Manner for Hindlimb Ischemia Therapy.Pharmaceutics2019https://conductscience.org/library/papers/30965617PubMed
29915185Assessment of Lower-limb Vascular Endothelial Function Based on Enclosed Zone Flow-mediated Dilation.Sci Rep2018https://conductscience.org/library/papers/29915185PubMed
25952975Origin and differentiation of vascular smooth muscle cells.J Physiol2015https://conductscience.org/library/papers/25952975PubMed
6825783Endothelial cell coat modifications in rat thoracic aorta. Effect of ovariectomy and cigarette smoke.Experientia1983https://conductscience.org/library/papers/6825783PubMed
2430278Purification and partial characterization of prostate-derived growth factor.Proc Natl Acad Sci U S A1986https://conductscience.org/library/papers/2430278PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/379462

GET https://conductscience.org/api/papers/v1/379462/authors